Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for separating lymphocytes

A separation method and liquid separation technology, applied in the biological field, can solve the problems of cumbersome steps, easy fatigue, time-consuming and labor-intensive, etc., and achieve the effect of reasonable ratio and small uncertainty of raw materials.

Inactive Publication Date: 2016-05-11
北京弘润天源基因生物技术有限公司
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Moreover, the current gradient centrifugation method has cumbersome steps, strong skills, and relatively high requirements for the operator's experience: gradient centrifugation requires three steps, especially the second step. Density of the cell suspension without mixing the interface, which greatly tests the operator's experience and patience, time-consuming, laborious, and prone to fatigue, and once the liquid level is mixed, the separation effect will be greatly affected, and even the lymphocyte layer cannot be separated
Moreover, most of the current separation fluids have certain toxicity, which affects the separation effect and the quality of the separated cells, resulting in low separation efficiency.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] In an environment with local 100-level laminar flow purification conditions, at 20°C, dextran 3g, trehalose 4g, ultra-low viscosity sodium alginate 0.8g, diatrizoate meglumine 1g, polydiallyl 0.15 g of dimethyl ammonium chloride was fully dissolved in sterile water for injection to prepare 100 mL of a physiological solution, and then filtered through a 0.22 μm filter membrane into a sterile, endotoxin-free container.

Embodiment 2

[0027] In an environment with local 100-level laminar flow purification conditions, at 20°C, dextran 5g, trehalose 2g, ultra-low viscosity sodium alginate 0.3g, diatrizoate meglumine 3g, polydiallyl 0.1 g of dimethyl ammonium chloride was fully dissolved in sterile water for injection to prepare 100 mL of a physiological solution, and then filtered through a 0.22 μm filter membrane into a sterile, endotoxin-free container.

Embodiment 3

[0029] In an environment with local 100-level laminar flow purification conditions, at 20°C, 3.5g of dextran, 3.5g of trehalose, 0.4g of ultra-low viscosity sodium alginate, 2.5g of diatrizoate, poly 0.15 g of diallyl dimethyl ammonium chloride was fully dissolved in sterile water for injection to prepare 100 mL of a physiological solution, and then filtered through a 0.22 μm filter membrane into a sterile, endotoxin-free container.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Densityaaaaaaaaaa
Osmotic pressureaaaaaaaaaa
Viscosityaaaaaaaaaa
Login to View More

Abstract

The invention discloses a method for separating lymphocytes and belongs to the technical field of biology. The method comprises the following steps: fully dissolving the following components that meet the medical standards: 3 to 5 parts by weight of dextran, 2 to 4 parts by weight of mycose, 0.3 to 0.8 part by weight of sodium alginate with an ultralow viscosity, 1 to 3 parts by weight of meglumine diatrizoate, and 0.1 to 0.15 part by weight of poly(diallyl dimethyl ammonium chloride) into sterile water to prepare 100 parts by weight of physiological solution; filtering the physiological solution by a filter membrane to remove the bacteria to obtain a separated liquid; adding the separated liquid into a centrifuge tube, wherein the volume of the separated liquid is not more than 1 / 2 of the volume of the centrifuge tube; paving a sample, which has been processed by an anticoagulant and diluted by a balanced salt solution or serum-free culture medium, on the separated liquid, carrying out centrifugation for 10 to 30 minutes at a temperature of 8 to 25 DEG C under a gravity of 200 to 800 g; wherein the sample is derived from peripheral blood, umbilical cord blood or marrow. The obtained lymphocytes have a good tumor killing activity.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a separation method for separating lymphocytes. Background technique [0002] During the standard separation process, the cells must be in contact with the separation medium for 15-45 minutes to achieve the best separation effect. During this period, the components in the separation solution may accumulate inside the cells through passive diffusion, active cell transport, endocytosis / pinocytosis, surface adhesion, etc., and this part of the accumulated components is difficult to pass through conventional methods Washing completely removes the isolated target cells (eg, lymphocytes). [0003] Moreover, the current gradient centrifugation method has cumbersome steps, strong skills, and relatively high requirements for the operator's experience: gradient centrifugation requires three steps, especially the second step. Density of the cell suspension without confusing the interface will...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/0781C12N5/0783
CPCC12N5/0635C12N5/0636C12N2500/30C12N2500/34C12N2500/46C12N2509/10
Inventor 宫喜魁李若鲲马艳马艳玲郝丽敏
Owner 北京弘润天源基因生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products